Antimyocardial Autoantibodies (AMCA)

Maurizio Rinaldi, Roberto Perricone, Carlo Perricone, Yehuda Shoenfeld

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


It is clear that in many patients, autoantibodies are produced after a myocardial injury. It is less clear whether such autoantibodies have clinical significance. In addition, infection with specific microbial agents may also produce antimyocardial antibodies. Interestingly, in nested subgroups of patients, the presence of antimyocardial antibodies is predictive of clinical outcome including disease progression. However, further studies need to be done and improvements are required for the actual immunoassays.

Original languageEnglish
Title of host publicationAutoantibodies
Subtitle of host publicationThird Edition
PublisherElsevier B.V.
Number of pages7
ISBN (Print)9780444563781
StatePublished - Dec 2013


  • Antiepinephrine
  • Antimyosin
  • Autoimmune diseases
  • Autoimmunity
  • Dilated cardiomyopathies


Dive into the research topics of 'Antimyocardial Autoantibodies (AMCA)'. Together they form a unique fingerprint.

Cite this